Abbott's Sales Soared in Q1, but Not Enough to Satisfy Wall Street
Abbott Laboratories (NYSE: ABT) entered 2020 as a strong and growing business. Then the COVID-19 pandemic hit, and the company became even stronger, with much faster growth.
The healthcare giant announced its first-quarter results before the market opened on Tuesday. Here are the highlights from that update.
Image source: Getty Images.
Source Fool.com
